This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2024 Apr 4;143(14):1317-1318.

doi: 10.1182/blood.2023023576.

A treatment bridge for infants with hemophilia

Thomas C Abshire¹

Affiliations

PMID: 38573607
DOI: 10.1182/blood.2023023576

Free article

Editorial

A treatment bridge for infants with hemophilia

Thomas C Abshire. Blood. 2024.

Free article

. 2024 Apr 4;143(14):1317-1318.

doi: 10.1182/blood.2023023576.

Author

Thomas C Abshire¹

Affiliation

¹ Versiti Blood Research Institute and Medical College of Wisconsin.

PMID: 38573607
DOI: 10.1182/blood.2023023576

No abstract available

PubMed Disclaimer

Comment on

Emicizumab prophylaxis in infants with hemophilia A (HAVEN 7): primary analysis of a phase 3b open-label trial.
Pipe SW, Collins P, Dhalluin C, Kenet G, Schmitt C, Buri M, Jiménez-Yuste V, Peyvandi F, Young G, Oldenburg J, Mancuso ME, Kavakli K, Kiialainen A, Deb S, Niggli M, Chang T, Lehle M, Fijnvandraat K. Pipe SW, et al. Blood. 2024 Apr 4;143(14):1355-1364. doi: 10.1182/blood.2023021832. Blood. 2024. PMID: 38127586 Free PMC article. Clinical Trial.

References

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Silverchair Information Systems
Medical
- MedlinePlus Health Information